1. Analysing coverage decision-making: opening Pandora’s box?. (2014). Leidl, Reiner ; Blankart, Katharina ; Fischer, Katharina.
   In: The European Journal of Health Economics.
   RePEc:spr:eujhec:v:15:y:2014:i:9:p:899-906.

   Full description at Econpapers || Download paper

2. Funding Decisions for Newborn Screening: A Comparative Review of 22 Decision Processes in Europe. (2014). Blankart, Katharina ; Rogowski, Wolf Henning ; Fischer, Katharina Elisabeth .
   In: IJERPH.
   RePEc:gam:jijerp:v:11:y:2014:i:5:p:5403-5430:d:36212.

   Full description at Econpapers || Download paper

3. AN ECONOMIC THEORY OF THE FOURTH HURDLE. (2013). Rogowski, WH.
   In: Health Economics.
   RePEc:wly:hlthec:v:22:y:2013:i:5:p:600-610.

   Full description at Econpapers || Download paper

4. Link between Process and Appraisal in Coverage Decisions. (2013). Blankart, Katharina ; Rogowski, Wolf H ; Stollenwerk, Bjrn.
   In: Medical Decision Making.
   RePEc:sae:medema:v:33:y:2013:i:8:p:1009-1025.

   Full description at Econpapers || Download paper

5. Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis. (2013). Leidl, Reiner ; Blankart, Katharina ; Rogowski, Wolf H. ; Fischer, Katharina E. ; Stollenwerk, Bjorn.
   In: Health Policy.
   RePEc:eee:hepoli:v:112:y:2013:i:3:p:187-196.

   Full description at Econpapers || Download paper

6. A systematic review of coverage decision-making on health technologies—Evidence from the real world. (2012). Blankart, Katharina ; Fischer, Katharina Elisabeth .
   In: Health Policy.
   RePEc:eee:hepoli:v:107:y:2012:i:2:p:218-230.

   Full description at Econpapers || Download paper

1. Anell, A. Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committees. 2004 European Journal of Public Health. 5 28-35

2. Anttila, A. ; Ronco, G. Description of the national situation of cervical cancer screening in the member states of the European Union. 2009 European Journal of Cancer. 45 708-2685
   Paper not yet in RePEc: Add citation now
   
3. Anttila, A. ; von Karsa, L. ; Aasmaa, A. ; Fender, M. ; Patnick, J. ; Rebolj, M. ; Nicula, F. ; Vass, L. ; Valerianova, Z. ; Voti, L. ; Sauvaget, C. ; Ronco, G. Cervical cancer screening policies and coverage in Europe. 2009 European Journal of Cancer. 45 58-2649
   Paper not yet in RePEc: Add citation now
   
4. Barbieri, M. ; Hawkins, N. ; Sculpher, M. Who does the numbers? The role of third-party technology assessment to inform health systems’ decision-making about the funding of health technologies. 2008 Value Health. -
   Paper not yet in RePEc: Add citation now
   

5. Bekkering, G.E. ; Kleijnen, J. Procedures and methods of benefit assessments for medicines in Germany. 2008 Eur J Health Econ. 9 5-29

6. Cairns, J. Providing guidance to the NHS: the Scottish Medicines Consortium and the National Institute for Clinical Excellence compared. 2006 Health Policy. 76 134-143

7. Carlsson, P. Health technology assessment and priority setting for health policy in Sweden. 2004 Int J Technol Assess Health Care. 20 44-54
   Paper not yet in RePEc: Add citation now
   
8. Chalkidou, K. ; Tunis, S. ; Lopert, R. ; Rochaix, L. ; Sawicki, P.T. ; Nasser, M. Comparative effectiveness research and evidence-based health policy: Experience from four countries. 2009 The Milbank Quarterly. 87 339-367
   Paper not yet in RePEc: Add citation now
   

9. Dakin, H.A. ; Devlin, N.J. ; Odeyemi, I.A. Yes”, “No” or “Yes, but”? Multinomial modelling of NICE decision-making. 2006 Health Policy. 77 352-367

10. Devlin, N. ; Parkin, D. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. 2004 Health Economics. 13 437-452

11. Gutierrez-Ibarluzea, I. ; Asua, J. ; Latorre, K. Policies of screening for colorectal cancer in European countries. 2008 International Journal of Technology Assessment in Health Care. 24 6-270
    Paper not yet in RePEc: Add citation now
    

12. Haas, M. ; Ashton, T. ; Blum, K. ; Christiansen, T. ; Conis, E. ; Crivelli, L. Drugs, sex, money and power: an HPV vaccine case study. 2009 Health Policy. 92 288-295

13. Hofmarcher, M.M. ; Rack, H.-M. Austria: Health system review. 2006 Health Systems in Transition. 8 1-247
    Paper not yet in RePEc: Add citation now
    
14. Holland, W. ; Stewart, S. . 2005 Screening in Disease Prevention: What Works? London: Radcliffe Publishing Ltd. -
    Paper not yet in RePEc: Add citation now
    
15. Hutton, J. ; McGrath, C. ; Frybourg, J.M. ; Tremblay, M. ; Bramley-Harker, E. ; Henshall, C. Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems). 2006 International Journal of Technology Assessment in Health Care. 22 10-18
    Paper not yet in RePEc: Add citation now
    
16. Leidl, R. Promoting economic value in public health. 2008 European Journal of Public Health. 18 216-
    Paper not yet in RePEc: Add citation now
    

17. Meckley, L.M. ; Neumann, P.J. Personalized medicine: factors influencing reimbursement. 2010 Health Policy. 94 91-100

18. Neumann, U. ; Hagen, A. ; Schönermark, M. Regulation der Aufnahme von innovativen nichtmedikamentösen Technologien in den Leistungskatalog solidarisch finanzierter Kostenträger. 2007 GMS Health Technology Assessment. 3 1-163
    Paper not yet in RePEc: Add citation now
    
19. Rogowski, W.H. ; Hartz, S.C. ; John, J.H. Clearing up the hazy road from bench to bedside: a framework for integrating the fourth hurdle into translational medicine. 2008 BMC Health Services Research. 8 194-
    Paper not yet in RePEc: Add citation now
    
20. Schreyögg, J. ; Stargardt, T. ; Velasco-Garrido, M. ; Busse, R. Defining the “Health Benefit Basket” in nine European countries. Evidence from the European Union Health BASKET Project. 2005 Eur J Health Econ. 2-10
    Paper not yet in RePEc: Add citation now
    
21. Taylor, R.S. ; Drummond, M.F. ; Salkeld, G. ; Sullivan, S.D. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. 2004 BMJ. 329 972-975
    Paper not yet in RePEc: Add citation now
    

22. Vuorenkoski, L. ; Toiviainen, H. ; Hemminki, E. Decision-making in priority setting for medicines: a review of empirical studies. 2008 Health Policy. 86 1-9

23. Williams, I. ; McIver, S. ; Moore, D. ; Bryan, S. The use of economic evaluations in NHS decision-making: a review and empirical investigation. 2008 Health Technol Assess. 12 -
    Paper not yet in RePEc: Add citation now
    
24. Zentner, A. ; Velasco-Garrido, M. ; Busse, R. Methoden zur vergleichenden Bewertung pharmazeutischer Produkte. Informationssystem Health Technology Assessment (HTA) in Deutschland. 2005 Deutsche Agentur für Health Technology Assessment des Deutschen Instituts für Medizinische Dokumentation und Information (DAHTA@DIMDI): Cologne
    Paper not yet in RePEc: Add citation now
    

1. Promoting innovation while controlling cost: The UKs approach to health technology assessment. (2022). Mossialos, Elias ; Carter, Paul ; Drummond, Michael ; Anderson, Michael ; Taylor, David ; McGuire, Alistair.
   In: Health Policy.
   RePEc:eee:hepoli:v:126:y:2022:i:3:p:224-233.

   Full description at Econpapers || Download paper

2. Applying an Implementation Framework to the Use of Evidence from Economic Evaluations in Making Healthcare Decisions. (2019). Zardo, Pauline ; Graves, Nicholas ; Page, Katie ; Merlo, Gregory.
   In: Applied Health Economics and Health Policy.
   RePEc:spr:aphecp:v:17:y:2019:i:4:d:10.1007_s40258-019-00477-4.

   Full description at Econpapers || Download paper

3. Shedding light on the HTA consultancy market: Insights from Poland. (2019). Kalo, Zoltan ; Ozieraski, Piotr ; Loblova, Olga ; Csanadi, Marcell ; King, Lawrence ; Botz, Lajos.
   In: Health Policy.
   RePEc:eee:hepoli:v:123:y:2019:i:12:p:1237-1243.

   Full description at Econpapers || Download paper

4. Health Technology Assessments - Evidence Based Approach for A Sustainable Future of Healthcare. (2019). Kumar, Narendra ; Barman, Manish ; Palak, Barman.
   In: Biomedical Journal of Scientific & Technical Research.
   RePEc:abf:journl:v:20:y:2019:i:3:p:14966-14969.

   Full description at Econpapers || Download paper

5. Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries. (2018). Kanavos, Panos ; Angelis, Aris ; Lange, Ansgar.
   In: The European Journal of Health Economics.
   RePEc:spr:eujhec:v:19:y:2018:i:1:d:10.1007_s10198-017-0871-0.

   Full description at Econpapers || Download paper

6. How do individuals value health states? A qualitative investigation. (2017). Brazier, John ; Paisley, S ; Karimi, M.
   In: Social Science & Medicine.
   RePEc:eee:socmed:v:172:y:2017:i:c:p:80-88.

   Full description at Econpapers || Download paper

7. Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia. (2016). Stargardt, Tom ; Blankart, Katharina ; Heisser, Thomas ; Fischer, Katharina Elisabeth .
   In: Health Policy.
   RePEc:eee:hepoli:v:120:y:2016:i:10:p:1115-1122.

   Full description at Econpapers || Download paper

8. Bridging the Gap: Exploring the Barriers to Using Economic Evidence in Healthcare Decision Making and Strategies for Improving Uptake. (2015). Graves, Nicholas ; Page, Katie ; Halton, Kate ; Ratcliffe, Julie ; Merlo, Gregory.
   In: Applied Health Economics and Health Policy.
   RePEc:spr:aphecp:v:13:y:2015:i:3:p:303-309.

   Full description at Econpapers || Download paper

9. A Comparative Analysis of Two Contrasting European Approaches for Rewarding the Value Added by Drugs for Cancer: England Versus France. (2014). Haig, Jennifer ; Cawston, Helene ; Saba, Grece ; Pouvourville, Gerard ; Jones, Elizabeth ; Drummond, Michael.
   In: PharmacoEconomics.
   RePEc:spr:pharme:v:32:y:2014:i:5:p:509-520.

   Full description at Econpapers || Download paper

10. Analysing coverage decision-making: opening Pandora’s box?. (2014). Leidl, Reiner ; Blankart, Katharina ; Fischer, Katharina.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:15:y:2014:i:9:p:899-906.

    Full description at Econpapers || Download paper

11. A Systematic Review of Cost-Sharing Strategies Used within Publicly-Funded Drug Plans in Member Countries of the Organisation for Economic Co-Operation and Development. (2014). Husereau, Don ; Harris, Anthony ; Lorenzetti, Diane ; Donaldson, Cam ; Manns, Braden ; Klarenbach, Scott ; Blom, Marja ; Barnieh, Lianne ; Clement, Fiona.
    In: PLOS ONE.
    RePEc:plo:pone00:0090434.

    Full description at Econpapers || Download paper

12. The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Countries: The Case of Tanzania. (2014). Norheim, Ole Frithjof ; Ngalesoni, Frida ; Kaale, Eliangiringa Amos ; Robberstad, Bjarne ; Mori, Amani Thomas.
    In: PLOS ONE.
    RePEc:plo:pone00:0084824.

    Full description at Econpapers || Download paper

13. Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making. (2013). Franken, Margreet ; Koopmanschap, Marc ; Nilsson, Fredrik ; Sandmann, Frank ; Boer, Anthonius.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:31:y:2013:i:9:p:781-797.

    Full description at Econpapers || Download paper

14. Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisions. (2012). Kanavos, Panos ; Nicod, Elena.
    In: Health Policy.
    RePEc:eee:hepoli:v:108:y:2012:i:2:p:167-177.

    Full description at Econpapers || Download paper

15. A systematic review of coverage decision-making on health technologies—Evidence from the real world. (2012). Blankart, Katharina ; Fischer, Katharina Elisabeth .
    In: Health Policy.
    RePEc:eee:hepoli:v:107:y:2012:i:2:p:218-230.

    Full description at Econpapers || Download paper

16. Reimbursement of pharmaceuticals: reference pricing versus health technology assessment. (2011). Stargardt, Tom ; Drummond, Michael ; Jonsson, Bengt.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:12:y:2011:i:3:p:263-271.

    Full description at Econpapers || Download paper

17. How Long and How Well. (2011). Neumann, Peter J ; Ubel, Peter A ; Kozminski, Michael A ; Nadler, Eric S ; Jankovic, Aleksandra.
    In: Medical Decision Making.
    RePEc:sae:medema:v:31:y:2011:i:3:p:380-385.

    Full description at Econpapers || Download paper

18. A thematic analysis of the strengths and weaknesses of manufacturers’ submissions to the NICE Single Technology Assessment (STA) process. (2011). Dickson, Rumona ; Fitzgerald, Patrick ; Kaltenthaler, Eva ; Carroll, Christopher ; Boland, Angela.
    In: Health Policy.
    RePEc:eee:hepoli:v:102:y:2011:i:2:p:136-144.

    Full description at Econpapers || Download paper

19. A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and prevention. (2011). Leidl, Reiner ; Blankart, Katharina ; Rogowski, Wolf H. ; Fischer, Katharina E..
    In: Health Policy.
    RePEc:eee:hepoli:v:101:y:2011:i:3:p:290-299.

    Full description at Econpapers || Download paper

20. Procedures and methods of benefit assessments for medicines in Germany: give the child a name. (2009). Falck-Ytter, Yngve ; Kunz, Regina ; Santesso, Nancy ; Schunemann, Holger.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:10:y:2009:i:2:p:237-238.

    Full description at Econpapers || Download paper

21. Response to the expertise: Procedures and methods of benefit assessments for medicines in Germany, by Geertruida E. Bekkering and Jos Kleijnen. (2009). Lange, Stefan ; Koch, Klaus .
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:10:y:2009:i:2:p:233-236.

    Full description at Econpapers || Download paper

22. Does social marketing provide a framework for changing healthcare practice?. (2009). Morris, Zoe Slote ; Clarkson, Peter John .
    In: Health Policy.
    RePEc:eee:hepoli:v:91:y:2009:i:2:p:135-141.

    Full description at Econpapers || Download paper

23. Preisregulierung von verschreibungspflichtigen Arzneimitteln in der gesetzlichen Krankenversicherung nach dem GKV-Wettbewerbsstärkungsgesetz. (2008). Wasem, Juergen ; Kotting, Cosima ; May, Uwe ; Gre, Stefan ; Klaucke, Lena .
    In: IBES Diskussionsbeiträge.
    RePEc:zbw:udewwd:170.

    Full description at Econpapers || Download paper

24. Balancing health and industrial policy objectives in the pharmaceutical sector: Lessons from Australia. (2008). Morgan, Steve ; McMahon, Meghan ; Greyson, Devon.
    In: Health Policy.
    RePEc:eee:hepoli:v:87:y:2008:i:2:p:133-145.

    Full description at Econpapers || Download paper

25. Reimbursement and clinical guidance for pharmaceuticals in Sweden. (2005). Anell, Anders ; Persson, Ulf.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:6:y:2005:i:3:p:274-279.

    Full description at Econpapers || Download paper

Report date: 2025-10-05 21:29:54 || Missing content? Let us know